<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>24(1)</volume><submitter>Zafar A</submitter><journal>BMC cancer</journal><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11536716</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Safety and efficacy of PD-1/PD-L1 immune checkpoint inhibitors in patients with pre-treated advanced stage malignant mesothelioma: a systematic review and meta-analysis</pubmed_title><pmcid>PMC11536716</pmcid><pubmed_authors>Zafar A</pubmed_authors><pubmed_authors>Rashid A</pubmed_authors><pubmed_authors>Khan A</pubmed_authors><pubmed_authors>Shrateh O</pubmed_authors><pubmed_authors>Ahmed A</pubmed_authors><pubmed_authors>Moeed A</pubmed_authors><pubmed_authors>Tahir M</pubmed_authors></additional><is_claimable>false</is_claimable><name>Safety and efficacy of PD-1/PD-L1 immune checkpoint inhibitors in patients with pre-treated advanced stage malignant mesothelioma: a systematic review and meta-analysis</name><description/><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Jan</publication><modification>2025-04-04T03:06:25.465Z</modification><creation>2025-04-04T03:06:25.465Z</creation></dates><accession>S-EPMC11536716</accession><cross_references/></HashMap>